Christina Schug
Munich, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
The sodium iodide symporter (NIS) as theranostic gene: its emerging role in new imaging modalities and non-viral gene therapy.
Journal: EJNMMI research
Published: October 07, 2021
Regional Hyperthermia Enhances Mesenchymal Stem Cell Recruitment to Tumor Stroma: Implications for Mesenchymal Stem Cell-Based Tumor Therapy.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: June 05, 2020
Radiation-Induced Amplification of TGFB1-Induced Mesenchymal Stem Cell-Mediated Sodium Iodide Symporter (NIS) Gene 131I Therapy.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 14, 2018
TGFB1-driven mesenchymal stem cell-mediated NIS gene transfer.
Journal: Endocrine-related cancer
Published: July 25, 2018
A Novel Approach for Image-Guided 131I Therapy of Pancreatic Ductal Adenocarcinoma Using Mesenchymal Stem Cell-Mediated NIS Gene Delivery.
Journal: Molecular cancer research : MCR
Published: February 23, 2018
Reintroducing the Sodium-Iodide Symporter to Anaplastic Thyroid Carcinoma.
Journal: Thyroid : official journal of the American Thyroid Association
Published: October 17, 2017
Hypoxia-targeted 131I therapy of hepatocellular cancer after systemic mesenchymal stem cell-mediated sodium iodide symporter gene delivery.
Journal: Oncotarget
Published: April 25, 2016
Last Updated: 09/26/2026